Literature DB >> 32033849

Lower respiratory infections mortality among Brazilians under-five before and after national pneumococcal conjugate vaccine implementation.

Paulo Camargos1, Cristiana M Nascimento-Carvalho2, Renato Teixeira3, Elisabeth França3.   

Abstract

BACKGROUND: Studies on the impact of pneumococcal conjugate vaccines (PCV) on mortality, especially among preschoolers are scarce. We aimed to assess time trend mortality from lower respiratory infections (LRI), taken as a proxy of pneumonia, from 1990 to 2017.
METHODS: This ecological study assessed the mortality rate among Brazilians under-five before and after the national PCV-10 implementation in 2010. Pneumococcal meningitis (PM) and diarrheal diseases (DD) were included as a "positive and negative controls", respectively. Trend analysis was performed through Global Burden of Disease estimates. Joinpoint regression modeling was used to describe trends in mortality and to identify time points of its statistically significant decreases throughout the study period.
RESULTS: There was a sustainable reduction in mortality rates for these three diseases, with no relevant changes in the secular trends for LRI and PM after the PCV-10 implementation. For LRI, PM, and DD the higher and statistically significant (p < 0.05) annual percent change reduction occurred between 2000 and 2003, (-8.3%), 1997-2000 (-11.9%), and 1990-1994. (-13.8%), respectively, i.e., several years before the nationwide implementation of PCV-10. Moreover, for LRI the annual percent change (from -5.9 to -8.8) verified from 1990 to 2009, i.e., 20 years before countrywide vaccination, was comparable to that observed during the PCV era, that is, from minus 5.8 to minus 7.8, between 2010 and 2017.
CONCLUSION: Mortality from LRI, PM, and DD decreased over time, irrespective of national PCV-10 implementation in Brazil. Other factors such as healthcare delivery, socioeconomic status improvement, and health interventions may have impacted this secular trend.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mortality; PCV 10; Pneumococcal conjugate vaccine; Pneumonia; Vaccine effectiveness

Mesh:

Substances:

Year:  2020        PMID: 32033849     DOI: 10.1016/j.vaccine.2020.01.084

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Effect of pneumococcal conjugate vaccines on mortality from lower respiratory infections and pneumonia among under-fives.

Authors:  Paulo Camargos; Linjie Zhang; Cristiana M Nascimento-Carvalho
Journal:  Hum Vaccin Immunother       Date:  2020-07-30       Impact factor: 3.452

2.  Sickle cell disease related mortality in Brazil, 2000-2018.

Authors:  Augusto Hasiak Santo
Journal:  Hematol Transfus Cell Ther       Date:  2020-12-05

3.  Impact after 10-year use of pneumococcal conjugate vaccine in the Brazilian national immunization program: an updated systematic literature review from 2015 to 2020.

Authors:  Adriana Guzman-Holst; Eliana de Barros; Pilar Rubio; Rodrigo DeAntonio; Otavio Cintra; Ariane Abreu
Journal:  Hum Vaccin Immunother       Date:  2021-03-18       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.